Inhibition of Borna Disease Virus Replication by Ribavirin
AUTOR(ES)
Jordan, Ingo
FONTE
American Society for Microbiology
RESUMO
The guanosine analogue ribavirin was tested for antiviral activity in two neural cell lines, human oligodendrocytes and rat glia, against Borna disease virus (BDV) strains V and He/80. Ribavirin treatment resulted in lower levels of virus and viral transcripts within 12 h. Addition of guanosine but not adenosine resulted in a profound reduction of the ribavirin effect. Ribavirin appears to be an effective antiviral agent for treatment of BDV infection in vitro. A likely mechanism for its activity is reduction of the intracellular GTP pool, resulting in inhibition of transcription and capping of BDV mRNAs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=104326Documentos Relacionados
- Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells.
- Borna Disease Virus Persistence Causes Inhibition of Glutamate Uptake by Feline Primary Cortical Astrocytes†
- Genome trimming: A unique strategy for replication control employed by Borna disease virus
- Mechanism of La Crosse virus inhibition by ribavirin.
- In vivo inhibition of respiratory syncytial virus by ribavirin.
